Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 83, Issue 2, Pages 119-128Publisher
WILEY
DOI: 10.1111/j.1440-1711.2005.01319.x
Keywords
adjuvant; immune response; immunotherapy; ISCOM; ISCOMATRIX
Categories
Ask authors/readers for more resources
The immunostimulating complex or 'iscom' was first described 20 years ago as an antigen delivery system with powerful immuno stimulating activity. Iscoms are cage-like structures, typically 40 nm in diameter, that are comprised of antigen, cholesterol, phospholipid and saponin. ISCOM(TM)-based vaccines have been shown to promote both antibody and cellular immune responses in a variety of experimental animal models. This review focuses on the evaluation of ISCOM(TM)-based vaccines in animals over the past 10 years, as well as examining the progress that has been achieved in the development of human vaccines based on ISCOM(TM) adjuvant technology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available